Thompson Siegel & Walmsley LLC Axogen, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.43 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
180Shares Held
36.4MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$74.2 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$58.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$54.5 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$52.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$44 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $767M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...